Citing the infamous case of Theranos, the now-debunked blood-testing startup, a student asked me about the risk of fraud in technology-company investing. Given the complexity of new technologies and the detailed knowledge needed to assess them, how do we judge the value of new technology as a basis for investment? The good news is that […]
